BOSTON--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today provided updates on multiple kidney diseases in its pipeline ...

SonoThera to Present at ASN Kidney Week 2024 Demonstrating the Potential of Novel Nonviral Ultrasound-Mediated Gene Therapy ...

A WhatsApp message has earned Moderna a reprimand from the UK's Prescription Medicines Code of Practice Authority (PMCPA), ...

for APOL1-mediated kidney disease, in phase 3, and early-stage candidate VX-407 for autosomal dominant polycystic kidney disease. Bank of America analysts said in a research note that the deal ...

I currently hold the title of Senior Research Fellow in Nephrology. Research interests Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic disease affecting the kidney ...

Paradigm Biopharmaceuticals (ASX:PAR) says it will submit its revised protocol for its long-awaited phase III trial for dodgy ...

The center's research focus is on the type of PKD called autosomal dominant polycystic kidney disease (ADPKD), which mainly affects adults. The center has three core facilities that provide both Mayo ...

Native nephrectomy in patients with autosomal dominant polycystic kidney disease in the kidney transplant program - single-center retrospective results of 2000-2020.

Climate change is driving more extreme heat and more air pollution from wildfires, each of which put human health at risk.

Just how dominant was Georgia's defense vs the Texas Longhorns? The Georgia Bulldogs picked up a massive win this weekend against the Texas Longhorns on the road as they walked out of Austin ...

Chronic kidney disease (CKD) is defined as a progressive loss of renal function that lasts for more than 3 months, and is classified according to the degree of kidney damage – measured by the le ...